Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
Stephen Harnicar, Sherry Mathew Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA Abstract: Nowhere has targeted therapy been more successful in the hematologic malignancy arena than chronic myelogenous leukemia (CML). By targeting the BCR–ABL fusion oncog...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2014
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/86bb35367d5e4a31b6d06b29616cc28c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|